• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Curr Top Med Chem. Novel Drugs Targeting the SARS-CoV-2/COVID-19 Machinery

tetano

Editor, Senior Moderator
Curr Top Med Chem. 2020 May 16. doi: 10.2174/1568026620999200517043137. [Epub ahead of print]
Novel Drugs Targeting the SARS-CoV-2/COVID-19 Machinery.


Sternberg A[SUP]1[/SUP], McKee DL[SUP]2[/SUP], Naujokat C[SUP]3[/SUP].

Author information




Abstract

Like other human pathogenic viruses, coronavirus SARS-CoV-2 employs sophisticated macromolecular machines for viral host cell entry, genome replication and protein processing. Such machinery encompasses SARS-CoV-2 envelope spike (S) glycoprotein required for host cell entry by binding to the ACE2 receptor, viral RNA-dependent RNA polymerase (RdRp) and 3-chymotrypsin-like main protease (3Clpro/Mpro). Under the pressure of the accelerating COVID-19 pandemic caused by the outbreak of SARSCoV- 2 in Wuhan, China in December 2019, novel and repurposed drugs were recently designed and identified for targeting the SARS-CoV-2 reproduction machinery, with the aim to limit spread of SARS-CoV-2 and morbidity and mortality of the COVID-19 pandemic.
Copyright? Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.



KEYWORDS:

3Clpro; COVID-19; Camostat; Coronavirus SARS-CoV-2; RNA polymerase; Remdesivir; S protein; α-Ketoamides.


PMID:32416679DOI:10.2174/1568026620999200517043137
 
Back
Top Bottom